Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CanSino Biologics Receives NMPA Approval for DTcP Hib MCV4 Combined Vaccine
CompanyDrug

CanSino Biologics Receives NMPA Approval for DTcP Hib MCV4 Combined Vaccine

February 25, 2025
MGI Tech Partners with Oncoclínicas&Co to Advance Precision Medicine in Brazil
CompanyDeals

MGI Tech Partners with Oncoclínicas&Co to Advance Precision Medicine in Brazil

February 25, 2025
Boehringer Ingelheim's Nerandomilast Receives NMPA Review for IPF Treatment
CompanyDrug

Boehringer Ingelheim’s Nerandomilast Receives NMPA Review for IPF Treatment

February 25, 2025
QYuns Therapeutics' QX002N Meets Primary Endpoint in AS Phase III Study
CompanyDrug

QYuns Therapeutics’ QX002N Meets Primary Endpoint in AS Phase III Study

February 25, 2025
Takeda's Takhzyro Receives EMA Approval for New Administration Form in HAE Patients
CompanyDrug

Takeda’s Takhzyro Receives EMA Approval for New Administration Form in HAE Patients

February 25, 2025
National Allied Procurement Office Allows VBP Winners to Adjust MAH and Manufacturing Details
Policy / Regulatory

National Allied Procurement Office Allows VBP Winners to Adjust MAH and Manufacturing Details

February 24, 2025
Ipsen Posts 8.7% Revenue Growth in 2024, Driven by Rare Diseases and Oncology
Company

Ipsen Posts 8.7% Revenue Growth in 2024, Driven by Rare Diseases and Oncology

February 24, 2025
Meyer FSMP Hong Kong Secures NMPA Approval for First FSMP in Greater China
CompanyDrug

Meyer FSMP Hong Kong Secures NMPA Approval for First FSMP in Greater China

February 24, 2025
Pfizer Halts Global Development of Hemophilia B Gene Therapy Beqvez Amid Limited Demand
CompanyDeals

Pfizer Halts Global Development of Hemophilia B Gene Therapy Beqvez Amid Limited Demand

February 24, 2025
Jointown Pharmaceutical Partners with Shandong DYNE to Boost Pediatric Drug Distribution
CompanyDeals

Jointown Pharmaceutical Partners with Shandong DYNE to Boost Pediatric Drug Distribution

February 24, 2025
CSPC Pharmaceutical Initiates Phase III Trial for Ammuxetine in Depression Treatment
CompanyDrug

CSPC Pharmaceutical Initiates Phase III Trial for Ammuxetine in Depression Treatment

February 24, 2025
Subtle Medical Integrates DeepSeek with FDA-Approved SupMR AI Platform
CompanyMedical Device

Subtle Medical Integrates DeepSeek with FDA-Approved SupMR AI Platform

February 24, 2025
1 2 … 4 5 6 7 8 … 26 27
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up